期刊文献+

对传统中医药临床疗效评价问题的思考 被引量:27

Pondering the problems of clinical effect assessment of traditional Chinese medicine
暂未订购
导出
摘要 临床疗效是中医药的生命,建立在严谨、科学基础上的中医临床疗效评价方法,是中医药临床研究发展之重心。本文分析了目前中医药临床疗效评价的现状,并针对当前的评价方法提出完善的思路,以期建立能体现中医药治疗的优势和特色、同时被国际认可的疗效评价体系。 Clinical effect is of great importance to traditional Chinese medicine (TCM). and the rigorous and scientific methods for clinical effect assessment should be highly stressed in the clinical research of TCM.In this article, the authors analyzed the current status of the effect assessment of TCM and proposed some measures to improve the current effect assessment of TCM, in the hope of establishing an internationally accepted system of effect assessment reflecting the superiority and characteristics of TCM therapies.
出处 《中西医结合学报》 CAS 2005年第3期181-183,共3页 Journal of Chinese Integrative Medicine
关键词 中国医药学 结果评价 临床研究 临床疗效 Chinese medicine and pharmacology outcome assessment clinical studies
  • 相关文献

参考文献5

  • 1Cochrane Complementary Medicine Field[A].In: The Cochrane Library[C]. Issue 3. Oxford: Update Software, 1999.
  • 2Hunt SM, McKenna SP, McEwen J, et al. The Nottingham Health Profile: subjective health status and medical consultations[J]. Soc Sci Med, 1981, 15 (13 Pt 1): 221-229.
  • 3Bergner M, Bobbit RA, Pollard WE, et al. The sickness impact profile: validation of a health status measure[J]. Med Care, 1976, 14(1): 57-67.
  • 4Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being[J]. Health Serv Res, 1976, 11(4): 478-507.
  • 5胡大一,顼志敏.临床医学模式转变—从经验医学到循证医学[J].中国实用内科杂志,1998,18(11):688-689. 被引量:27

二级参考文献10

  • 1Echt DS,Leibson PR,Mitchel LB,et al.Cardiac arrhythmia suppression trial.N Engl Med,1989;321:406.
  • 2GISSI investigators.Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction.
  • 3USUS-2 Collaborative group.Randomized trial of intravenous streptokinase,oral aspirin,both,or neither among 17187 cases of suspected acute myocardial infarction:ISIS-2 Lancet,1988;Ⅱ:349.
  • 4The TIMI Ⅲ A investigators.Early effects of tissue-type plasminogen activator added to convention therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest.Results of the thrombolysis in myocardial ischemia(TIMI II A) trial. Circulation, 1993;87:38.
  • 5The TIMI ⅢB investigators.Effects of tissue plasminogen.activator and a comparison of early invasive and conservative strategies in umtable angina and non-Q wave myocardial infarction.Results of the TIMI ⅢB trial Circulation, 1994;89:1545.
  • 6The Scandinavian Simvastatin Survival Study Guoup.Randomized trial of cholesterol lowering in 4444 patients with coronary heart disesse:the Scandinavian Simvastatin Survival Study(4S).Lancet,1994;344:1383.
  • 7Sacks FM, Pfeffer MA, Moye LA,et al.The effect of pravastatin on coronary events after myocardial irfarction in patients with average cholesterol levels.N Engl J Med,1996;335:1001.
  • 8The LIPID Study group. Design features and baseline characteristics of the LIPID Study:a randomized trial in Patients with previous acute myocardial infarction and/or unstable angina pectoris.Am J Cardiol, 1995;76:474.
  • 9Amiodarone Trial Meta-Analysis Investigators.Effect of prophylactic amiodarone on motality after acute myocardial infarction and in congestive heart failure:meta-analysis of individual data from 6500 patients in randomized trials.Lancet,1997;35):1417.
  • 10Chinese Cardiac Study Collaborative Group.Oral captopil versus placebo among 13 634 patients with suspected acute myocardial infarction:interim report from the Chinese Cardiac Study(CCS-1).Iancet,1995;345:686.

共引文献26

同被引文献281

引证文献27

二级引证文献221

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部